Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Heart failure study aims to tailor treatments using biomarkers

NCT ID NCT07647848

First seen Jun 20, 2026 · Last updated Jun 23, 2026 · Updated 1 time

Summary

This observational study will follow 600 adults with chronic or acute heart failure to see how biomarkers and other factors predict individual responses to standard medications. Participants will have assessments at the start and after 1, 3, and 6 months, with follow-up phone calls every 6 months. The goal is to improve personalized treatment strategies for heart failure.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC HEART FAILURE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could help doctors personalize heart failure treatments based on individual biomarkers, improving outcomes.

What could go wrong

This is an observational study, not a treatment trial, so it won't directly test a new therapy. Results may not lead to immediate changes in care.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.